General Information
Drug ID
DR01345
Drug Name
Okadaic acid
Synonyms
78111-17-8; CHEMBL280487; CHEBI:44658; C44H68O13; 9,10-Deepithio-9,10-didehydroacanthifolicin; Ocadaic Acid; OKA; (2R)-3-[(2S,5R,6R,8S)-8-[(2R,3E)-4-[(2R,4'aR,5R,6'S,8'R,8'aS)-8'-hydroxy-6'-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-7'-methylidene-hexahydro-3'H-spiro[oxolane-2,2'-pyrano[3,2-b]pyran]-5-yl]but-3-en-2-yl]-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl]-2-hydroxy-2-methylpropanoic acid; UNII-1W21G5Q4N2; CCRIS 3329; HSDB 7243; 1W21G5Q4N2; 1jk7
Drug Type
Small molecular drug
Indication Alzheimer disease [ICD11: 8A20] Preclinical [1]
Structure
3D MOL 2D MOL
Formula
C44H68O13
Canonical SMILES
CC1CCC2(CCCCO2)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)O)O)O)C)O)O
InChI
InChI=1S/C44H68O13/c1-25-21-34(55-44(23-25)35(46)12-11-31(54-44)24-41(6,50)40(48)49)26(2)9-10-30-14-18-43(53-30)19-15-33-39(57-43)36(47)29(5)38(52-33)32(45)22-28(4)37-27(3)13-17-42(56-37)16-7-8-20-51-42/h9-10,23,26-28,30-39,45-47,50H,5,7-8,11-22,24H2,1-4,6H3,(H,48,49)/b10-9+/t26-,27-,28+,30+,31+,32+,33-,34+,35-,36-,37+,38+,39-,41-,42+,43-,44-/m1/s1
InChIKey
QNDVLZJODHBUFM-WFXQOWMNSA-N
CAS Number
CAS 78111-17-8
Pharmaceutical Properties Molecular Weight 805 Topological Polar Surface Area 183
Heavy Atom Count 57 Rotatable Bond Count 10
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 13
XLogP
3.4
PubChem CID
446512
PubChem SID
584236 , 823554 , 3153140 , 7889572 , 7980368 , 10299908 , 14840618 , 16018839 , 24897998 , 24898069 , 26697137 , 36888909 , 46393288 , 47216553 , 49857808 , 50762076 , 53789776 , 57404748 , 91701779 , 104005410 , 104234157 , 104636588 , 137024288 , 137179375 , 162187529 , 162228448 , 178102011 , 186014503 , 208011843 , 226500271 , 251911561 , 252355519
ChEBI ID
CHEBI:44658
TTD Drug ID
D01SLG
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Okadaic acid: more than a diarrheic toxin. Mar Drugs. 2013 Oct 31;11(11):4328-49.
2 Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg Med Chem. 2012 Sep 15;20(18):5388-95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.